Ovaries are absolutely required for development of the mammary parenchyma (PAR) in cattle, reflecting estrogendependent epithelial cell proliferation. However, the estrogen receptor (ER) that mediates the mammary estrogen effects, ERa, is absent in proliferating epithelial cells. In the mouse, this discrepancy is explained in part by the ability of the mammary fat pad (MFP) to synthesize epithelial cell mitogens such as IGF-I in response to estrogen. Consistent with a similar role for the bovine MFP, 30% of its fibroblasts and adipocytes were immunoreactive for ERa in prepubertal dairy heifers. To assess estrogen-dependent gene expression in the MFP, 16 prepubertal dairy heifers were randomly assigned to a 2!2 factorial. The first factor was ovarian status, with heifers undergoing bilateral ovariectomy or left intact at 4$6 months of age. The second factor was applied 30 days after surgery and consisted of injection of estrogen or excipient. After 3 days of injection, heifers were administered an intrajugular bolus of bromodeoxyuridine (BrdU) and slaughtered 2 h later. The estrogen injection, but not ovarian status, caused significant increases in the fraction of epithelial cells labeled with BrdU and produced tissue-specific effects on gene expression. In the PAR, estrogen injection increased IGF-I gene expression by twofold despite reductions of 50% or more in ERa mRNA abundance and the fraction of epithelial cells immunoreactive for ERa. The estrogendependent increase in IGF-I mRNA was greater in the MFP, presumably because estrogen failed to downregulate ERa expression in this mammary compartment. Finally, estrogenresponsiveness of the MFP appears unique among the bovine fat depots as estrogen injection did not induce IGF-I expression in its s.c. counterpart. Our data demonstrate that the bovine MFP is highly responsive to exogenous estrogen, consistent with a role for this tissue compartment in communicating its effects on epithelial cell proliferation.
Introduction
In prepubertal cattle, development of the mammary parenchyma (PAR) is severely impaired when ovaries are removed soon after birth (Wallace 1953 , Purup et al. 1993 , Berry et al. 2003b ). This impairment is caused, at least in part, by a lower rate of mammary epithelial cell proliferation in ovariectomized heifers (Berry et al. 2003b) . Conversely, prepubertal mammary development in ovariectomized heifers is restored by the administration of an estrogenic compound (Wallace 1953 ). These observations suggest that the effects of ovaries on the developing PAR are mediated by estrogen.
The estrogen effects are mediated predominantly by the estrogen receptor a (ERa) in the mammary gland (Couse & Korach 1999 , Connor et al. 2005 . Paradoxically, most bovine mammary epithelial cells that proliferate in response to exogenous estrogen do not express ERa .
This lack of overlap between ERa expression and proliferation has also been observed in the rat, mouse and human mammary epithelial cells (Zeps et al. 1998 , Russo et al. 1999 , Saji et al. 2000 . These observations led to the hypothesis that non-epithelial, ERa-positive cells play an important role in mediating estrogen effects. According to this model, these cells respond to estrogen by secreting growth factors, which stimulate proliferation of neighboring, ERa-negative epithelial cells. A well-studied example of such a mammary epithelial cell mitogen is insulin-like growth factor-I (IGF-I; Shamay et al. 1988) . IGF-I is synthesized exclusively by nonepithelial cells in the bovine PAR (Plath-Gabler et al. 2001 , Berry et al. 2003a ) and its transcription is increased by estrogen (Umayahara et al. 1994) .
Most studies in cattle have been largely epitheliocentric and have not considered the possibility that the mammary fat pad (MFP) plays a role in mediating the effects of estrogen on the PAR (Akers et al. 2005) . The bovine MFP consists predominantly of adipocytes and fibroblasts, and both cell types have been shown to account for most of the nonepithelial, ER-positive cells required for normal epithelial development in the prepubertal mouse (Cunha et al. 1997) . Finally, estrogen administration to prepubertal cattle stimulates epithelial cell proliferation to the greatest extent in the parenchymal region adjacent to the MFP . These observations suggest that the bovine MFP could be involved in communicating the influence of estrogen on the developing PAR. Finally, the possibility that the MFP responds differently to estrogen than s.c. adipose tissue (SQA), as shown in rodents (Walden et al. 1998) , has not been examined in cattle.
To address these questions, we asked whether significant levels of immunoreactive ERa were present in the MFP. We then varied plasma estrogen levels by subjecting prepubertal heifers to bilateral ovariectomy (OVX) and exogenous estrogen administration, and examined the expression of IGF-I and progesterone receptor (PR) genes in MFP, PAR and SQA. Our data show that the MFP expresses significant levels of ERa and has a greater ability to produce IGF-I in response to estrogen than either the PAR or SQA.
Materials and Methods

Animals
The Cornell University Animal Care and Use Committee approved all the procedures used in this study. To evaluate the presence of ERa in the MFP, six heifers were purchased from commercial dairy farms and moved at day 10 of life to the Cornell Research Center. They were offered milk replacer until weaning (8$4 weeks) and a complete total ration thereafter at rates needed to sustain an average daily gain of 650 g/day. Heifers were slaughtered when their body weight was 150 kg, by stunning with a captive bolt and exsanguination. The mammary gland was removed immediately and split into right and left halves. Tissues were dissected from the mid-MFP and fixed overnight in 10% neutral buffered formalin at 4 8C and stored in 70% ethanol.
To assess the effects of estrogen on gene expression, 16 prepubertal Holstein heifers were purchased at 3$2 months of age from a single commercial dairy farm and transported to the Cornell Research Center. Thereafter, they were fed a complete total ration at rates needed to sustain an average daily gain of 650 g/day. After an acclimatization period of 45 days, they were randomly assigned to a 2!2 factorial. The first factor was ovarian status, with eight heifers each undergoing bilateral OVX at 4$6 months (106 kg), or left intact (INT). Ovaries were accessed via a laparoscopic technique under halothane anesthesia and removed using diathermy methodology. The second factor was applied after a surgery recovery period of 30 days and consisted of daily s.c. injection of 17b-estradiol (Cestrogen) or excipient (corn oil, Kestrogen). Estrogen was administrated at a dose of 0$1 mg/kg body weight as previous work has demonstrated that this dose elicits an increase in mammary epithelial cell proliferation in the prepubertal bovine (Woodward et al. 1993 , Berry et al. 2001 . Injections were administered on 3 consecutive days. Approximately, 4 h after the last injection, heifers were given an intrajugular dose of bromodeoxyuridine (BrdU, 5 mg/kg body weight) as described previously . Heifers were killed 2 h later (or 54 h after initial injection) by captive bolt stunning and exsanguination. The mammary gland was removed and weighed. Mid-PAR and MFP were obtained from the left half of the mammary gland and SQA was obtained from the brisket region. All tissues were snap frozen in liquid nitrogen for later RNA isolation. Additional PAR and MFP samples were fixed overnight in 10% neutral buffered formalin at 4 8C and stored in 70% ethanol until processed for immunohistochemistry.
Following tissue collection, the gland was skinned and separated into right and left halves at the medial suspensory ligament. The skin and teats from the whole gland were weighed together and the skinned right half was weighed separately. The weight of the skinned left half was determined by difference. The cervix, uterus, and uterine horns were excised and weighed and at this time, successful OVX was confirmed in all eight OVX heifers by visual appraisal.
Jugular blood was collected daily at 0700 h during the 8-day period preceding OVX and again between days 7 and 14 following surgery. During the injection period, blood was collected at 0, 12, 24, 36, and 48 h after the initial injection. Plasma was prepared by centrifugation and assayed for 17b-estradiol with a commercial RIA kit (Estradiol Maia, Adaltis Italia S.p.A., Casalecchio di Reno, BO, Italy) as described previously by Beam & Butler (1997) .
Immunohistochemistry
Immunohistochemical detection of ERa and BrdU was performed exactly as described previously by bright field microscopy . Briefly, the primary antibody for ERa localization was mouse monoclonal antibody C-311 produced against amino acid sequence 405-595 of the bovine ERa (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) and the primary antibody for BrdU was mouse monoclonal antibody clone BMC 9318 (Chemicon International, Inc., Temecula, CA, USA). To quantify the number of ERa and BrdU labeled cells, photographs of stained sections were captured as digital images with a Spot digital camera (Diagnostic Instruments, Inc., Sterling Heights, MI, USA) on a Zeiss Axioskop microscope (Carl Zeiss, Inc., Thornwood, NY, USA) at a magnification of 400!. For each antibody, ten random areas were photographed from a single stained slide containing 3-4 sections. Labeled cells and total cells per micrograph were counted manually. A minimum of 4000 cells per animal was scored for each immunohistochemical analysis.
RNA isolation and quantitative real-time reverse transcriptase (RT)-PCR
Total RNA was isolated using the RNeasy Lipid Tissue Mini kit with on-column DNase digestion (Qiagen). Quality and quantity of the DNase-treated RNA were determined using the Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA). DNase-treated RNA (990 ng) was reverse transcribed using the iScript cDNA Synthesis Kit as recommended by the manufacturer (Bio-Rad Laboratories). Transcript abundance was determined by SYBR green quantitative real-time RT-PCR (iQ SYBR Green Supermix; Bio-Rad Laboratories). A total of 1$0 ml of the RT reaction was used in the 25 ml PCR. Primers and PCR conditions for evaluation of ERa, ERb, PR, and estrogen-related receptor a (ERRa) were as described (Connor et al. 2005) . Forward and reverse primers for evaluation of IGF-I gene expression were 5 0 -CATCCTCCTCGCATCTCTTC-3 0 and 5 0 -GCACAC-GAACTGGAGAGC-3 0 respectively (T m Z57$0 8C; 118-bp product). Amplicons were verified for each assay by sizing on an Agilent 2100 Bioanalyzer and sequencing. Sample concentrations were determined from a standard curve of known target cDNA copy numbers (1!10 2 -1!10 7 molecules).
Statistical analysis
Data were analyzed by a mixed model accounting for ovarian status (ovary, OVX, or INT), 17b-estradiol injection (estrogen, Kestrogen, or Cestrogen) and their interaction as fixed effects, and heifer as the random effect. To compare estrogen responsiveness across tissues, a fractional estrogen response was calculated for the IGF-I and PR data as follows. The copy number for each estrogen-treated heifer was subtracted from basal copy number and expressed as percentage of basal copy number. The basal copy number corresponds to the average of all oil-treated heifers. These data were analyzed by a mixed model accounting for ovarian status (ovary, OVX, or INT), tissue (PAR, MFP, or SQA) and their interaction as fixed effects, and heifer as the random effect. Unless otherwise mentioned the level of statistical significance was set at P!0$05.
Results
Immunodetection of ERa in the MFP
We recently reported negligible ERb, but significant ERa, expression in MFP of prepubertal dairy heifers (MJ Meyer, RP Rhoads, AV Capuco, EE Connor, YR Boisclair and ME Van Amburgh, unpublished observations). The expression of ERa in the MFP was not obvious, given that it was found nearly exclusively in epithelial cells in the PAR . To determine if ERa is expressed in the MFP, we performed immunohistochemistry on an initial group of prepubertal heifers when weighing 150 kg. The ERa signal was clearly seen and localized to 33%G6 of all fibroblasts and 31%G3 of all adipocytes. A similar result is evident in micrographs obtained in the INT heifers used to evaluate estrogen effects in the MFP (Fig. 1 , MFP, row A).
Effect of estrogen status on plasma estrogen and tissue weight
To compare estrogen effects in PAR, MFP, and SQA, we used ovariectomized and intact heifers treated with or without exogenous estrogen. Prior to OVX, the plasma estrogen concentration fluctuated between the detectable limit of 0$06 pg/ml and approximately 4$5 pg/ml in all heifers. A week after surgery, the plasma estrogen concentration dropped to near or below the detectable limit in OVX heifers. Within 12 h of the first estrogen injection, the plasma estrogen concentration reached an average of 385 pg/ml in both OVX and INT heifers and stayed at this level for the duration of the injection period. Therefore, treatments caused expected changes in plasma estrogen. Next, we assessed the effectiveness of treatments on tissue growth. Body weight at slaughter was not affected by ovarian status or estrogen injection. Short-term estrogen administration had no effect on PAR weight but caused a 79% increase in uterine weight ( Fig. 2 , P!0$05). OVX tended to reduce uterine weight by 31% (Fig. 2 , P!0$14), but only led to a non-significant 23% reduction in PAR. To obtain a dynamic measure of treatment effects on the mammary gland, we quantified the percentage of PAR epithelial cells labeled after bolus administration of the thymidine analog BrdU. OVX elicited a non-significant 30% reduction in the percentage of BrdU-labeled epithelial, whereas estrogen injection increased labeling by over threefold irrespective of the ovarian status ( Fig. 3 , P!0$05). Overall, these data show that increased plasma estrogen has functional consequences on mammary epithelial cells.
Effect of estrogen on gene expression in PAR, MFP, and SQA
Ovarian status had no effect on expression of the ERa, ERRa, IGF-I, and PR genes in the PAR (Table 1) . In contrast, exogenous estrogen caused a 50% reduction in ERa transcript abundance (Table 1 , P!0$01). This reduction reached 80% when the response examined was the fraction of mammary epithelial cells displaying ERa immunoreactivity (Figs 1 and 4, P!0$05). Despite reduced parenchymal ERa expression, exogenous estrogen stimulated the expression of estrogen-responsive genes, causing a 1$4-fold increase in the case of IGF-I and a 5-fold increase in the case of PR (Table 1 , P!0$01).
As seen in the PAR, estrogen injection caused gene expression responses in the MFP (Table 1) . Estrogen injection caused a similar absolute increase in IGF-I transcript copy number in both INT and OVX heifers, and a greater increase in PR transcripts in OVX than in INT heifers (Ovary! estrogen, P!0$01). In contrast to what was seen in the PAR, however, estrogen injection failed to reduce ERa transcript abundance in the MFP. Consistent with the mRNA result, estrogen injection did not induce a reduction in the number of cells displaying ERa immunoreactivity in the MFP of either INT or OVX heifers (Fig. 1) .
Finally, SQA responses differed from the MFP and PAR in two ways. First, the SQA was the only tissue where both ovarian status and estrogen injection caused significant changes in ERa transcript abundance (31% increase in OVX and 32% reduction with estrogen injection, P!0$06 or less; Table 1 ). Sensitivity of SQA to OVX was not explained by the presence of the other ER isoform (ERb) as its expression was below our lowest standard (results not shown). Second, unlike MFP and PAR, the SQA did not increase IGF-I or PR gene expression in response to estrogen injection.
In the oil-treated heifers, absolute copy number for the IGF-I and PR transcripts differ 3 to 13-fold between PAR, MFP, and SCA, making the cross-tissue comparison of estrogen responsiveness difficult. To perform a relative comparison, copy number for each estrogen-treated heifer was subtracted from basal copy number and expressed as percentage of basal copy number. In this analysis, the basal copy number corresponds to the average of all excipienttreated heifers as the initial analysis indicated that ovarian status had no effect (Table 1) . For IGF-I, the MFP was more estrogen responsive than the PAR, whereas the SQA completely failed to mount any estrogen-dependent response (Fig. 5 , tissue, P!0$05). For PR, the SQA also failed to respond, but only the MFP from INT heifers appeared to be more responsive than PAR (ovary!tissue, P!0$05).
Discussion
Prepubertal mammary development is best understood in rodents (Hennighausen & Robinson 2005) . In these animals, normal ductal growth requires presence of the MFP and estrogen (Cunha et al. 1997 , Wiseman & Werb 2002 . This dual requirement is explained in part by the ability of estrogen to induce the synthesis of growth factors in the MFP. These growth factors bind to their cognate receptors in epithelial cells resulting in cell proliferation. Recent experiments in genetically engineered mice have identified IGF-I as one of these growth factors. Briefly, ductal growth is impaired in IGF-I knockout (KO) mice even after exogenous estrogen administration (Ruan & Kleinberg 1999) . IGF-I is required specifically by the epithelial compartment as shown by the failure of IGF-IR KO epithelium to grow when grafted in a wild-type MFP (Bonnette & Hadsell 2001) . Finally, the MFP produces IGF-I in an estrogen-dependent manner (Umayahara et al. 1994 , Walden et al. 1998 ) and sustains normal ductal growth even when plasma IGF-I is reduced (Richards et al. 2004) .
OVX early after birth also blocks mammary epithelial cell growth in cattle (Purup et al. 1993 , Berry et al. 2003b . In their study, Purup et al. (1993) measured low plasma estrogen concentration (0$31 ng/ml) in prepubertal dairy heifers, raising the possibility that another ovarian factor was responsible for prepubertal development. Recently, however, Evans et al. (1994a,b) detected peaks in plasma estrogen concentrations in prepubertal heifers, ranging from 2$8 to 5$7 pg/ml, as early as 2 months of age and continuing to estrus. Consistent with their findings, the plasma estrogen concentrations in our intact heifers often exceeded 4 pg/ml. Circulating estrogen in prepubertal cattle reflects repeating waves of non-ovulatory follicular growth initiated approximately every 8 days (Evans et al. 1994a, b) . These data strongly suggest that estrogen is the ovarian factor stimulating mammary epithelial cell growth in cattle.
The estrogen dose employed in the present study was chosen because an effect on mammary epithelial cell proliferation was assured (Woodward et al. 1993 , Berry et al. 2001 , however, the effect on plasma estrogen levels was not previously described. It is difficult to discern potential differences in response to physiological versus pharmacological (as observed in the present study) plasma estrogen, as such data do not exist.
As in the case of rodents, data available in cattle support a model whereby estrogen does not exclusively act directly on the mammary epithelium. Within the PAR compartment, immunoreactive ERa localizes almost entirely to epithelial cells, but is virtually absent from the subset of those cells engaged in proliferation. These proliferating cells are found in highest density at the interface with the MFP in estrogentreated heifers , suggesting a role for the MFP in mediating or amplifying mitogenic estrogen effects. To examine whether the bovine MFP is a major site of estrogen action in the mammary gland, we ovariectomized heifers at 4$6 month of age and collected tissues 30 days later. OVX caused comparable non-significant reduction in the weight of the mammary PAR and uterus. Failure to detect an OVX effect on the weight of these tissues likely relates to the small number of animals in which this was evaluated. A second important factor, however, is the timing of the OVX procedure. In previous studies, OVX before 2$5 months of age nearly ablated PAR growth measured 3$5-6$5 months later (Purup et al. 1993 , Berry et al. 2003a , but this effect was reduced when the OVX was performed after 8 weeks of age (Berry et al. 2003b) .
Consistent with a lack of effect on PAR mass, we were also unable to detect significant effects of OVX on dynamic measurements such as BrdU incorporation by mammary epithelial cells and IGF-I expression in the PAR and MFP compartments. These results are in contrast with those of Berry et al. (2003a, b) , where OVX reduced both epithelial BrdU incorporation and PAR IGF-I expression. Again, this discrepancy likely relates to their use of earlier OVX (1-3 months versus 4$6 months in our study) and a longer period of time between OVX and tissue collection (3-5 months versus 30 days in our study). Taken together, these data suggest that effects of endogenous estrogen are greater in the first 2 months of life than at later prepubertal ages. In support of this hypothesis, we recently showed that mammary epithelial BrdU incorporation was highest in w2-month heifers and declined steadily as they progress towards puberty ; MJ Meyer, AV Capuco, DA Ross, LM Lintault and ME Van Amburgh, unpublished observations). Obviously, the age-dependent effect of OVX on epithelial cell proliferation and gene expression will need to be examined in future studies.
In contrast, a 3-day period of estrogen administration caused a threefold increase in epithelial BrdU incorporation irrespective of ovarian status, similar to effects previously reported by others in intact prepubertal heifers . In parallel with increased proliferation, estrogen administration stimulated IGF-I transcript copy number by 1$4-fold in the PAR and 3$6-fold in the MFP. As bovine epithelial cells do not express IGF-I (Berry et al. 2003a) , the stimulation of IGF-I mRNA in the PAR must occur in ER-positive stromal cells. We have recently detected such cells in the interlobular stromal region of the PAR. Consistent with these data, Plath-Gabler et al. (2001) found that the only parenchymal cells displaying immunoreactive IGF-I signals were adipocytes and fibroblasts. In the case of the MFP, there is little doubt that residing adipocytes and fibroblasts are capable of estrogendependent IGF-I production. Adipose tissue compares with liver in terms of IGF-I gene expression (Coleman et al. 1994) and we now show that 30% of the adipocytes and fibroblasts present in the bovine MFP contain immunoreactive ERa. Finally, we sought to confirm estrogen responsiveness of the MFP by measuring expression of the PR gene. In rodents, this gene, essential for branching morphogenesis (Brisken et al. 1998) , is shown to be expressed in an estrogen-dependent manner (Kastner et al. 1990) . Our data show that estrogen treatment increased PR transcript copy number not only in the PAR, but also in the MFP, confirming the ability of the bovine MFP to mount estrogen responses. Our data indicate that estrogen treatment reduced the number of epithelial cells with immunoreactive ERa signal and that this effect reflects estrogen-dependent inhibition of ERa mRNA abundance. Significantly, this estrogen-dependent downregulation of ERa mRNA did not occur in the MFP. The ability of the MFP to retain high ERa expression despite the pharmacological estrogen levels may explain its greater IGF-I mRNA response. The physiological consequence of this property may be to blunt the fall of IGF-I production in the MFP as plasma estrogen levels rise during prepubertal development. Walden et al. (1998) showed that estrogen and growth hormone elicited a synergistic IGF-I response in the MFP of ovariectomized and hypophysectomized rats, but not in the SQA. This prompted us to ask whether the bovine MFP differed from its s.c. counterpart. The SQA expressed ERa at only 23% of the level seen in the MFP, and unlike the latter, failed to respond to exogenous estrogen administration by increasing IGF-I or PR expression. To define other possible bases for the lack of estrogen responsiveness in the SQA, we measured the expression levels for another major ER isoform (ERb) and the orphan receptor most related to ERa (ERRa). Both gene products have been implicated in the estrogen action, with ERb mediating estrogen effects in the adult rodent mammary gland (Cheng et al. 2004) and ERRa attenuating the ability of ERa to mediate the estrogen effects (Zhang & Teng 2001) . Our data do not support a role for either of those receptors in explaining differences in estrogen responsiveness as both fat depots had negligible levels of ERb expression and ERRa abundance did not differ between SQA and MFP. We conclude that variation in ERa expression is likely to explain the different estrogen responsiveness of SQA and MFP. In summary, the ability of the MFP to increase IGF-I expression is greater than that of its s.c. counterpart or the epithelial-rich PAR. This responsiveness endows the MFP with the ability to coordinate estrogen-mediated prepubertal development in the bovine mammary gland. Obviously, IGF-I is unlikely to be the only functionally important estrogendependent growth factor synthesized in the MFP, and for that matter in the PAR as well. Indeed, ER-positive epithelial cells present in the PAR could also secrete unknown mitogens in response to estrogen. The identification of the genes encoding these growth factors and other estrogen-dependent proteins should be advanced considerably by using the recently developed bovine oligonucleotide-based microarrays. 
